Atlas Trials

A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes

Clinical trial NCT03224234 · COMPLETED

Trial details

NCT number
NCT03224234
Sponsor
Emory University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes
Start date
2017-11-29
Primary completion
2019-09-18
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.